Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say

  • Australian health authorities have recommended against a fifth COVID-19 vaccine shot despite average daily cases having been 47% higher last week than the week before, said Health Minister Mark Butler at a press conference.
  • The authorities have urged eligible to sign up for their remaining booster doses amid growing cases, but remain 85% below the previous peak of late July.
  • Butler said the Australian Technical Advisory Group on Immunizations (ATAGI) had recommended against a fifth dose or the third booster, Reuters reported.
  • The recommendation follows evidence from Singapore's recent wave showed that severe illness and death were rare among the vaccinated and that a fifth shot had minimal impact on virus transmission.
  • Related: Moderna Says Omicron Tailored COVID-19 Shots Shows Better Immune Response Than Original Vaccine.
  • "ATAGI has considered international evidence as well as the local data around vaccination numbers and case numbers in the pandemic and decided not to recommend the fifth dose," said Butler.
  • "They noted that severe disease and death during that wave in Singapore was very rare for people who had had at least two doses of vaccine for COVID."
  • New booster recommendations will be made early next year ahead of the southern-hemisphere winter.
  • Butler also accepted ATAGI recommendations that Pfizer Inc's PFE omicron-specific vaccine be approved as a booster dose for adults; 4.7 million doses will arrive ahead of a rollout due to begin on December 12.
  • The company's vaccine for children aged six months to five years will also be approved for use on the severely immunocompromised.
  • Photo by Daniel Schludi on Unsplash
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!